<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
43835-0059-1
</NDCCode>
<PackageDescription>
9 CONTAINER in 1 BOX (43835-0059-1) / 160 SYRINGE, GLASS in 1 CONTAINER / .75 mL in 1 SYRINGE, GLASS
</PackageDescription>
<NDC11Code>
43835-0059-01
</NDC11Code>
<ProductNDC>
43835-0059
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Semaglutide
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20250101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Novo Nordisk Production Belgium SA
</LabelerName>
<SubstanceName>
SEMAGLUTIDE
</SubstanceName>
<StrengthNumber>
3.2
</StrengthNumber>
<StrengthUnit>
mg/.75mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-03-03
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
01-JAN-25
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>